{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:37Z","timestamp":1707524497955},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,27]]},"DOI":"10.7759\/cureus.23555","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T05:55:37Z","timestamp":1648446937000},"source":"Crossref","is-referenced-by-count":0,"title":["Biochemical Serum Markers Influencing Maternal Age Risk for Down's Syndrome in Quadruple Marker"],"prefix":"10.7759","author":[{"given":"Zehratul","family":"Quresh.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinni","family":"Dharavath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","article-title":"Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level","volume":"94","author":"Cuckle HS","year":"1987","unstructured":"Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987, 94:387-402. 10.1111\/j.1471-0528.1987.tb03115.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-017-0475-7","article-title":"Gender differences in the prevalence of congenital heart disease in Down's syndrome: a brief meta-analysis","volume":"18","author":"Diogenes TC","year":"2017","unstructured":"Diogenes TC, Mourato FA, de Lima Filho JL, Mattos SD. Gender differences in the prevalence of congenital heart disease in Down's syndrome: a brief meta-analysis. BMC Med Genet. 2017, 18:111. 10.1186\/s12881-017-0475-7","journal-title":"BMC Med Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.288","article-title":"Trends in maternal age distribution and the live birth prevalence of Down's syndrome in England and Wales: 1938-2010","volume":"21","author":"Wu J","year":"2013","unstructured":"Wu J, Morris JK. Trends in maternal age distribution and the live birth prevalence of Down's syndrome in England and Wales: 1938-2010. Eur J Hum Genet. 2013, 21:943-7. 10.1038\/ejhg.2012.288","journal-title":"Eur J Hum Genet"},{"key":"ref4","article-title":"Screening for Down syndrome","volume":"56","author":"Khalil A","year":"2006","unstructured":"Khalil A, Pandya P. Screening for Down syndrome. J Obstet Gynecol India. 2006, 56:205-11.","journal-title":"J Obstet Gynecol India"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.126980","article-title":"Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists","volume":"187","author":"Egan JF","year":"2002","unstructured":"Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF, Benn PA. Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol. 2002, 187:1230-4. 10.1067\/mob.2002.126980","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone FD","year":"2005","unstructured":"Malone FD, Canick JA, Ball RH, et al.. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005, 353:2001-11. 10.1056\/NEJMoa043693","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3310\/hta7110","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"7","author":"Wald NJ","year":"2003","unstructured":"Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 2003, 7:1-77. 10.3310\/hta7110","journal-title":"Health Technol Assess"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66320-2","article-title":"A retrospective analysis of different contingent screening models for fetal Down syndrome in Southwestern China","volume":"10","author":"Luo W","year":"2020","unstructured":"Luo W, He B, Han D, et al.. A retrospective analysis of different contingent screening models for fetal Down syndrome in Southwestern China. Sci Rep. 2020, 10:9457. 10.1038\/s41598-020-66320-2","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005922","article-title":"Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis","volume":"4","author":"Neyt M","year":"2014","unstructured":"Neyt M, Hulstaert F, Gyselaers W. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open. 2014, 4:e005922. 10.1136\/bmjopen-2014-005922","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2014.08.028","article-title":"The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis","volume":"182","author":"Beulen L","year":"2014","unstructured":"Beulen L, Grutters JP, Faas BH, Feenstra I, van Vugt JM, Bekker MN. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis. Eur J Obstet Gynecol Reprod Biol. 2014, 182:53-61. 10.1016\/j.ejogrb.2014.08.028","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093559","article-title":"Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service","volume":"9","author":"Morris S","year":"2014","unstructured":"Morris S, Karlsen S, Chung N, Hill M, Chitty LS. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service. PLoS One. 2014, 9:e93559. 10.1371\/journal.pone.0093559","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903093201001","article-title":"The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities","volume":"320","author":"Rhoads GG","year":"1989","unstructured":"Rhoads GG, Jackson LG, Schlesselman SE, et al.. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989, 320:609-17. 10.1056\/NEJM198903093201001","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003252","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","author":"Alfirevic Z","year":"2003","unstructured":"Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2003, CD003252. 10.1002\/14651858.CD003252","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1998.5335","article-title":"10 years of Genomics, chromosome 21, and Down syndrome","volume":"51","author":"Antonarakis SE","year":"1998","unstructured":"Antonarakis SE. 10 years of Genomics, chromosome 21, and Down syndrome. Genomics. 1998, 51:1-16. 10.1006\/geno.1998.5335","journal-title":"Genomics"},{"key":"ref15","article-title":"Fetal chromosomal abnormalities: antenatal screening and diagnosis","volume":"79","author":"Anderson CL","year":"2009","unstructured":"Anderson CL, Brown CE. Fetal chromosomal abnormalities: antenatal screening and diagnosis. Am Fam Physician. 2009, 79:117-23.","journal-title":"Am Fam Physician"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02723582","article-title":"Genetic counseling and prenatal diagnosis in India--experience at Sir Ganga Ram Hospital","volume":"70","author":"Verma IC","year":"2003","unstructured":"Verma IC, Saxena R, Lall M, Bijarnia S, Sharma R. Genetic counseling and prenatal diagnosis in India--experience at Sir Ganga Ram Hospital. Indian J Pediatr. 2003, 70:293-7. 10.1007\/BF02723582","journal-title":"Indian J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410709","article-title":"Prenatal screening for Down's syndrome: a search for the family's values","volume":"341","author":"Copel JA","year":"1999","unstructured":"Copel JA, Bahado-Singh RO. Prenatal screening for Down's syndrome: a search for the family's values. N Engl J Med. 1999, 341:521-2. 10.1056\/NEJM199908123410709","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89145-biochemical-serum-markers-influencing-maternal-age-risk-for-downs-syndrome-in-quadruple-marker","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:34Z","timestamp":1707507754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89145-biochemical-serum-markers-influencing-maternal-age-risk-for-downs-syndrome-in-quadruple-marker"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.23555","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,27]]}}}